Showing results (281-290 of 307) with videos related to
Sort By:
Pageof 31
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.Journal of Ethnopharmacology|March 8, 2024
Identification of anti-fibrotic and pro-apoptotic bioactive compounds from Ganoderma formosanum and their possible mechanisms in modulating TGF-β1-induced lung fibrosisKuan-Chen Cheng, Patrick Chun Theng Chong, Chen-Che Hsieh, et al.Cells|May 13, 2026
uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune IndicationsHandan Xiang, Grace Pham Mortenson, Simon B Lang, et al.Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.Translational Oncology|September 15, 2023
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathwaysHsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, et al.Science Translational Medicine|February 18, 2021
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyStephen P Chelko, Gizem Keceli, Andrea Carpi, et al.Cancer Research|February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptorBo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.Cancers|July 2, 2021
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma TreatmentHsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, et al.Nucleic Acids Research|November 16, 2017
HMDB 4.0: the human metabolome database for 2018David S Wishart, Yannick Djoumbou Feunang, Ana Marcu, et al.Pageof 31